Website & contact details
- Group website
- The site of this company’s group or brand.
Catalent Pharma Solutions Limited
- Incorporated
- 28 April 1999 (27 years)
- Previously known as
- Cardinal Health Holdings Limited (until 19 June 2007)Gac No.161 Limited (until 29 June 1999)
- Industry
- Activities of head offices (70100) Management consultancy activities other than financial management (70229)
- Directors
- Robert DerryRicky Wayne Hopson
- Owned by
- Novo Nordisk Fonden
- Accounts type
- Full
- Region
- South West
- Address
- Frankland RoadBlagroveSwindonSN5 8YG
Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 10 March 2027
- Last conf. stmt
- 24 February 2026
Officers 5 active
Officer details are public data from the Companies House register.
Derry, Robert, Mr.
Director · Appointed 1 July 2026
British
Born May 1976 (50)
Director · Appointed 1 April 2025
British
Born January 1977 (49)
Hopson, Ricky Wayne
Director · Appointed 4 December 2023
American
Born June 1975 (51)
Director · Appointed 2 October 2023
American
Born August 1969 (57)
Gennadios, Aristippos
Director · Appointed 8 December 2016
American
Born May 1965 (61)
Officer history (24 former)
1 July 2026
Appointed Derry, Robert, Mr. as Director
1 July 2026
1 April 2025
1 April 2025
4 December 2023
Appointed Hopson, Ricky Wayne as Director
2 October 2023
29 September 2023
13 September 2023
Resigned Fasman, Steven as Director
16 August 2023
Appointed Fasman, Steven as Director
21 April 2023
31 May 2022
31 May 2022
22 October 2021
Resigned Reed, Alex as Secretary
30 August 2019
Resigned Walsh, Kirk as Secretary
29 March 2018
29 March 2018
29 March 2018
Appointed Reed, Alex as Secretary
8 December 2016
Appointed Gennadios, Aristippos as Director
15 September 2013
15 September 2013
15 September 2013
15 September 2013
Resigned Joseph, Wetteny as Director
17 June 2013
Appointed Joseph, Wetteny as Director
17 June 2013
Resigned Hopson, Ricky as Director
29 May 2013
Appointed Hopson, Ricky as Director
29 May 2013
Resigned Wolff, Marc as Director
1 May 2010
Appointed Walsh, Kirk as Secretary
30 April 2010
31 July 2009
31 July 2009
12 March 2009
9 June 2008
6 June 2008
1 August 2007
Appointed Wolff, Marc as Director
3 April 2007
1 May 2006
6 August 2005
1 August 2005
Resigned Martin, Glenn Lawrence as Director
17 June 2005
17 June 2005
1 June 2001
30 May 2001
30 May 2001
30 May 2001
30 May 2001
Appointed Martin, Glenn Lawrence as Director
27 February 2001
Resigned Kane, John as Director
1 July 2000
Appointed Kane, John as Director
28 June 1999
25 June 1999
25 June 1999
25 June 1999
28 April 1999
28 April 1999
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Novo Nordisk Fonden
Corporate entity · Notified 6 April 2016
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Corporate
Group structure 4 companies
Ownership group derived from the Companies House PSC register
Catalent Pharma Solutions Limited This company
Catalent Oxford Limited Owns 50–75% of shares
Catalent U.K. Swindon Holding II Limited Owns 75–100% of shares
Catalent U.K. Swindon Zydis Limited Owns 75–100% of shares
Filings 162
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 17 September 2026 | Appointment of a director | |||
| 15 July 2026 | Termination of appointment of a director | |||
| 11 May 2026 | Full accounts | 31 December 2025 | ||
| 6 March 2026 | Confirmation statement with no updates | 24 February 2026 | ||
| 15 May 2025 | Change of details for a person with significant control |
Some other companies at this address
Other companies in this industry
London
London
Sunderland
London
Hertfordshire
By trade and location
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →